4.4 Article

The role of podoplanin inhibitors in controlling oral cancer progression

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Biochemistry & Molecular Biology

Mechanisms of Action and Limitations of Monoclonal Antibodies and Single Chain Fragment Variable (scFv) in the Treatment of Cancer

Cynthia Rodriguez-Nava et al.

Summary: Monoclonal antibodies are effective tools for detecting tumor-associated antigens, but they have limitations. Single-chain variable fragments are versatile and easy to produce, making them attractive for use in immunotherapy models. This review aims to describe the mechanisms of action, applications, and limitations of monoclonal antibodies and single-chain variable fragments in cancer treatment.

BIOMEDICINES (2023)

Review Cell Biology

Roles of Podoplanin in Malignant Progression of Tumor

Hiroyuki Suzuki et al.

Summary: Podoplanin plays a critical role in tumor development and normal development of various organs. It is overexpressed in tumors and influences platelet aggregation and signal transductions, thereby contributing to the malignant progression of tumors. Additionally, in the tumor microenvironment, Podoplanin expression is upregulated in the tumor stroma and immune cells, implicating its involvement in tumor development and immune evasion.
Article Biochemistry & Molecular Biology

Podoplanin Expression Independently and Jointly with Oral Epithelial Dysplasia Grade Acts as a Potential Biomarker of Malignant Transformation in Oral Leukoplakia

Luis Monteiro et al.

Summary: The study found that the expression levels of CD44v6, p53, p73, and podoplanin increase gradually along with the progression of oral leukoplakias. Furthermore, high levels of podoplanin expression were found to be associated with an increased risk of malignant transformation.

BIOMOLECULES (2022)

Review Dentistry, Oral Surgery & Medicine

Podoplanin could be a predictive biomarker of the risk of patients with oral leukoplakia to develop oral cancer: A systematic review and meta-analysisKeywords

Luis Monteiro et al.

Summary: This study aimed to evaluate the utility of podoplanin as a predictive biomarker for malignancy development in patients with oral leukoplakia. Meta-analysis of 6 studies showed that high expression of podoplanin is associated with an increased risk of malignancy. However, there are limitations in the included studies that need to be addressed in future research.

ORAL DISEASES (2022)

Review Pharmacology & Pharmacy

Oral Potentially Malignant Disorders: Etiology, Pathogenesis, and Transformation Into Oral Cancer

Pratima Kumari et al.

Summary: Oral cancer is a critical health issue, with the majority of new cases occurring in Asia. Various factors, such as genetics and lifestyle, are closely associated with its occurrence and progression. Early signs of oral cancer include oral lesions, genetic mutations, and viral infections. Lesions with dysplastic features have a high risk of malignancy, and OPMDs have a high prevalence in South Asian countries. Early detection, prevention, and treatment of OPMDs are crucial.

FRONTIERS IN PHARMACOLOGY (2022)

Article Oncology

Effects of Maackia amurensis seed lectin (MASL) on oral squamous cell carcinoma (OSCC) gene expression and transcriptional signaling pathways

Kelly L. Hamilton et al.

Summary: The study reveals that MASL inhibits the growth and migration of oral squamous cell carcinoma by decreasing the activity of JAK-STAT, TGF beta-SMAD, and Wnt-beta CTN signaling pathways. These findings suggest that MASL may be used alone or in combination with other agents for the treatment of oral cancer.

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2021)

Review Immunology

Platelet CLEC2-Podoplanin Axis as a Promising Target for Oral Cancer Treatment

Byeong-Oh Hwang et al.

Summary: Cancer tissues form complex and heterogeneous tumor microenvironments, where platelets play a crucial role in promoting cancer progression. In oral squamous cell carcinoma, high platelet counts and low tumor-stromal ratio are associated with increased metastasis and poor prognosis, suggesting that targeting the interaction between platelets and cancer cells could be a promising therapeutic strategy to inhibit cancer invasion and metastasis.

FRONTIERS IN IMMUNOLOGY (2021)

Review Oncology

Overview of Oral Potentially Malignant Disorders: From Risk Factors to Specific Therapies

Luigi Lorini et al.

Summary: Oral potentially malignant disorders (OPMDs) are a group of oral mucosal diseases that have the potential to develop into oral squamous cell carcinoma (OSCC). Early diagnosis is crucial for improving survival rates. The focus is on early detection techniques and the effectiveness of treatments.

CANCERS (2021)

Review Cell Biology

Podoplanin as an Attractive Target of CAR T Cell Therapy

Masazumi Waseda et al.

Review Environmental Sciences

Oral Cancer and Precancer: A Narrative Review on the Relevance of Early Diagnosis

Silvio Abati et al.

INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2020)

Review Biochemistry & Molecular Biology

Podoplanin in Inflammation and Cancer

Miguel Quintanilla et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)

Article Dentistry, Oral Surgery & Medicine

Podoplanin expression in oral leukoplakia-a prospective study

Kathrin J. Grochau et al.

JOURNAL OF CRANIO-MAXILLOFACIAL SURGERY (2019)

Article Food Science & Technology

Structure-function and application of plant lectins in disease biology and immunity

Abtar Mishra et al.

FOOD AND CHEMICAL TOXICOLOGY (2019)

Review Oncology

Chimeric antigen receptor T-cell therapy - assessment and management of toxicities

Sattva S. Neelapu et al.

NATURE REVIEWS CLINICAL ONCOLOGY (2018)

Review Oncology

Podoplanin: An emerging cancer biomarker and therapeutic target

Harini Krishnan et al.

CANCER SCIENCE (2018)

Article Dentistry, Oral Surgery & Medicine

Oral potentially malignant disorders: risk of progression to malignancy

Paul M. Speight et al.

ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY (2018)

Review Pharmacology & Pharmacy

Oral Field Cancerization and Its Clinical Implications in the Management in Potentially Malignant Disorders

Anisha Cynthia Sathiasekar et al.

JOURNAL OF PHARMACY AND BIOALLIED SCIENCES (2017)

Review Oncology

Platelet-activating factor podoplanin: from discovery to drug development

Ai Takemoto et al.

CANCER AND METASTASIS REVIEWS (2017)

Article Oncology

CAR T Cells Targeting Podoplanin Reduce Orthotopic Glioblastomas in Mouse Brains

Satoshi Shiina et al.

CANCER IMMUNOLOGY RESEARCH (2016)

Review Biochemistry & Molecular Biology

Lectins with Potential for Anti-Cancer Therapy

Tammy Yau et al.

MOLECULES (2015)

Article Health Care Sciences & Services

Expression of podoplanin in different grades of oral squamous cell carcinoma

B. Prasad et al.

ANNALS OF MEDICAL AND HEALTH SCIENCES RESEARCH (2015)

Article Hematology

Mechanistic explanation for platelet contribution to cancer metastasis

David Stegner et al.

THROMBOSIS RESEARCH (2014)

Article Multidisciplinary Sciences

A Cancer-specific Monoclonal Antibody Recognizes the Aberrantly Glycosylated Podoplanin

Yukinari Kato et al.

SCIENTIFIC REPORTS (2014)

Review Immunology

Podoplanin: emerging functions in development the immune system and cancer

Jillian L. Astarita et al.

FRONTIERS IN IMMUNOLOGY (2012)

Article Oncology

Podoplanin and ABCG2: Malignant Transformation Risk Markers for Oral Lichen Planus

Peng Shi et al.

CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2010)

Review Oncology

Global epidemiology of oral and oropharyngeal cancer

Saman Warnakulasuriya

ORAL ONCOLOGY (2009)

Article Biochemistry & Molecular Biology

Inhibition of tumor cell-induced platelet aggregation using a novel anti-podoplanin antibody reacting with its platelet-aggregation-stimulating domain

Yukinari Kato et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)

Article Cell Biology

Podoplanin binds ERM proteins to activate RhoA and promote epithelial-mesenchymal transition

Ester Martin-Villar et al.

JOURNAL OF CELL SCIENCE (2006)

Review Pharmacology & Pharmacy

Antinutritional properties of plant lectins

IM Vasconcelos et al.

TOXICON (2004)